Biograil

About:

Biograil is a biotech company manufacturing an oral device for delivery of biologics

Top Investors: Verve Ventures, HTGF | High-Tech Gruenderfonds, Arve Capital, Megatrend Invest, Swiss Investment group

Description:

Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body’s own peristaltic forces to facilitate the delivery of the biologic efficiently into the gastrointestinal wall.

Total Funding Amount:

3M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Copenhagen, Hovedstaden, Denmark

Founded Date:

2019-01-01

Founders:

John Barberich, Karsten Lindhardt, Nikolaj Skak

Number of Employees:

11-50

Last Funding Date:

2022-10-04

IPO Status:

Private

Industries: